Biogen (NASDAQ:BIIB) Stock Price Expected to Rise, Robert
2 days ago · Biogen (NASDAQ:BIIB - Get Free Report) had its target price boosted by Robert W. Baird from $294.00 to $300.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has an "outperform" rating on the biotechnology company's stock.
OFF
Biogen (NASDAQ:BIIB) Stock Price Expected To Rise, Robert
1 week from now
2 days ago · Biogen (NASDAQ:BIIB - Get Free Report) had its target price boosted by Robert W. Baird from $294.00 to $300.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has an "outperform" rating on the biotechnology company's stock.
marketbeat.com
OFF
Biogen (NASDAQ:BIIB) Stock Price Expected To Rise, Robert W.
1 week from now
10 hours ago · Shares of NASDAQ BIIB opened at $159.99 on Friday. Biogen has a 12 month low of $159.60 and a 12 month high of $268.30. The company has a market cap of $23.31 billion, …
defenseworld.net
OFF
Biogen (BIIB) Gets A Buy From TD Cowen - Markets Insider
1 week from now
2 days ago · TD Cowen analyst Phil Nadeau maintained a Buy rating on Biogen (BIIB – Research Report) today and set a price target of $275.00.The company’s shares closed yesterday at …
businessinsider.com
OFF
Biogen (BIIB) Stock Forecast And Price Target 2024 - MarketBeat
1 week from now
2 days ago · Robert W. Baird. 2 of 5 stars : Boost Target: Outperform Outperform: $294.00 $300.00 +81.94%: ... Here are some ways that investors could benefit from investing in Biogen …
marketbeat.com
OFF
Evaluating Biogen: Insights From 17 Financial Analysts
1 week from now
Nov 4, 2024 · The 12-month price targets, analyzed by analysts, offer insights with an average target of $253.47, a high estimate of $300.00, and a low estimate of $180.00.
nasdaq.com
OFF
Biogen (BIIB): Pioneering CNS Treatments And Future Growth …
1 week from now
Oct 16, 2024 · With a consensus Buy rating from industry analysts, Biogen’s (NASDAQ:BIIB) stock has a target price of $264.89, which represents a 33.75% upside potential from its …
yahoo.com
OFF
1 Wall Street Analyst Thinks Biogen Stock Is Going To $311. Is
1 week from now
Mar 2, 2024 · On Feb. 20, Cantor Fitzgerald analyst Eric Schmidt restated his aggressive price target for Biogen, (NASDAQ: BIIB) estimating that the biopharmaceutical stock will rise by …
nasdaq.com
OFF
Biogen (NASDAQ:BIIB) Stock, Analyst Ratings, Price Targets, …
1 week from now
Nov 4, 2024 · The latest price target for Biogen (NASDAQ:BIIB) was reported by JP Morgan on November 4, 2024. The analyst firm set a price target for $210.00 expecting BIIB to rise to …
benzinga.com
OFF
Why Biogen Stock Leaped Nearly 5% Higher Today
1 week from now
Apr 24, 2024 · Before market open on Wednesday, Biogen (BIIB-0.54%) unveiled its first earnings report of 2024. Happily, the company was far more profitable than many expected it to be, and …
fool.com
OFF
Biogen (NasdaqGS:BIIB) Stock Forecast & Analyst Predictions
1 week from now
Nov 8, 2024 · EPS is expected to grow by 14.3% per annum. Return on equity is forecast to be 13.2% in 3 years. ... Earnings Update: Biogen Inc. (NASDAQ:BIIB) Just Reported Its First …
simplywall.st
OFF
Biogen Inc. (BIIB) Expected To Beat Earnings Estimates: What To …
1 week from now
Oct 23, 2024 · This company is expected to post quarterly earnings of $3.78 per share in its upcoming report, which represents a year-over-year change of -13.3%. Revenues are …
yahoo.com
OFF
Biogen Stock: Cheapish, But With Few Growth Prospects - Seeking …
1 week from now
Jul 11, 2024 · Biogen's new restructuring aims to save $1 billion in expenses, with a FY25 forecast showing a potential revenue increase. Learn more about BIIB stock here.
seekingalpha.com
OFF
Biogen Stock Price Today (NASDAQ: BIIB) Quote, Market Cap, …
1 week from now
Biogen Inc. (BIIB) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release. ... (NASDAQ: BIIB) Biogen stock price per share is $173.04 today (as of Nov 8, 2024). What is …
wallstreetzen.com
OFF
Theravance's Q3 Loss Narrower Than Expected, Revenues Rise Y/Y
1 week from now
3 days ago · Biogen’s earnings beat estimates in three of the trailing four quarters and missed the same in one, delivering an average surprise of 9.99%. 7 Best Stocks for the Next 30 Days
nasdaq.com
OFF
Eli Lilly Falls More Than 10% In A Month: Buy, Sell Or Hold The Stock?
1 week from now
5 days ago · Lilly’s stock has risen 42.7% so far this year compared with an increase of 11.6% for the industry. The stock has also outperformed the sector as well as the S&P 500, as seen in …
nasdaq.com
OFF
IOVA Posts Narrower-Than-Expected Q3 Loss, Amtagvi Sales Drive …
1 week from now
Nov 8, 2024 · Biogen’s earnings beat estimates in three of the trailing four quarters and missed the mark once, delivering an average surprise of 9.99%. Free: 5 Stocks to Buy As …
nasdaq.com
OFF
Xenon Q3 Loss Narrower Than Expected, Pipeline Development In …
1 week from now
3 days ago · Image Source: Zacks Investment Research. General and administrative expenses were $16.7 million in the reported quarter, up 30% year over year. The significant rise was on …
nasdaq.com
OFF
Repligen Beats On Q3 Earnings & Sales, Narrows '24 Sales View
1 week from now
4 days ago · Adjusted EPS is anticipated to be between $1.50 and $1.58 in 2024 compared with the previously issued guidance of $1.42-$1.49. This raised EPS outlook is likely why …
nasdaq.com
FAQs about Biogen (NASDAQ:BIIB) Stock Price Expected to Rise, Robert Coupon?
Should you buy Biogen (BIIB) stock?
What is the price target for Biogen (BIIB)?
Is Biogen a good stock to buy?
What is Biogen (BIIB)'s market cap?
Does Biogen Inc (BIIB) pay a dividend?
What is Biogen stock price per share?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
